What is the EDCTP?
Poverty-related and neglected infectious diseases have a profound economic and social impact in developing countries. Tackling infectious diseases is central to delivering the Sustainable Development Goals, a high priority for the EU.
The European and Developing Countries Clinical Trials Partnership (EDCTP) is a public-public partnership between 14 European and 16 sub-Saharan African countries, supported by the European Union.
The EDCTP exists to accelerate the clinical development of new or improved medicinal products for the identification, treatment and prevention of poverty-related and neglected infectious diseases, including (re-)emerging diseases.
In addition, the EDCTP is making an important contribution for research capacity building in Africa, supporting researchers’ careers and strengthening national health research systems.
Focus and goals
The second EDCTP programme focuses on the key poverty-related infectious diseases affecting sub-Saharan Africa: tuberculosis, HIV, malaria, diarrhoeal diseases, lower respiratory tract infections, neglected infectious diseases, including emerging and re-emerging infections.
It has a particular focus on vulnerable populations who are often excluded from clinical trials, including pregnant women, infants, children, adolescents, and people with additional health conditions (co-infections and co-morbidities). It supports clinical trials, as well as implementation research.
EU contribution and budget
In addition to the European Participating States contributions to the partnership, since its launch in 2014, the European Commission has committed € 683 million of funding towards the EDCTP2.
Total funding for the 2014-2020 period is expected to be more than €1.4 billion.